Recent advances in research on Crimean-Congo hemorrhagic fever

Journal of Clinical Virology

Volumn 64, Issue , 2015, Pages 137-143

  Papa, Anna ^a   Mirazimi, Ali ^b,c,d   Köksal, Iftihar ^e   Estrada Pena, Augustin ^f   Feldmann, Heinz ^g  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Swedish Institute for Communicable Disease Control   (Sweden)

^c NATIONAL VETERINARY INSTITUTE   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^f UNIVERSITY OF ZARAGOZA   (Spain)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Crimean Congo hemorrhagic fever; Ecology; Epidemiology

Indexed keywords

RIBAVIRIN; ANTIVIRUS AGENT; VIRUS VACCINE;

ANIMAL HEALTH; ANTIVIRAL THERAPY; ARTICLE; CRIMEAN CONGO HEMORRHAGIC FEVER; DENDRITIC CELL; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; IXODIDAE; LABORATORY DIAGNOSIS; LYME DISEASE; MACROPHAGE; MORBIDITY; NONHUMAN; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; PROPHYLAXIS; TICK BITE; TICK BORNE ENCEPHALITIS; VIRUS TRANSMISSION; ANIMAL; COMMUNICABLE DISEASE; HEMORRHAGIC FEVER, CRIMEAN; IMMUNOLOGY; NAIROVIRUS; PATHOGENICITY; TICK; VIROLOGY; ZOONOSIS;

ANIMALS; ANTIVIRAL AGENTS; COMMUNICABLE DISEASES, EMERGING; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; TICKS; VIRAL VACCINES; ZOONOSES;

EID: 84923553145     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.08.029     Document Type: Article

References (91)

1. Papa A. Crimean-Congo hemorrhagic fever and hantavirus infections. Tropical and emerging infectious diseases 2010, 49-73. Research Signpost, Kerala, India. H. Maltezou, A. Gikas (Eds.).
2. Aradaib I.E., Erickson B.R., Mustafa M.E., Khristova M.L., Saeed N.S., Elageb R.M., et al. Nosocomial outbreak of Crimean-Congo hemorrhagic fever, Sudan. Emerg Infect Dis 2010, 16:837-839.
3. Naderi H.R., Sarvghad M.R., Bojdy A., Hadizadeh M.R., Sadeghi R., Sheybani F. Nosocomial outbreak of Crimean-Congo haemorrhagic fever. Epidemiol Infect 2011, 139:862-866.
4. Sargianou M., Papa A. Epidemiological and behavioural factors associated with CCHFV infections in humans. Expert Rev Anti Infect Ther 2013, 11:897-908.
5. Ergonul O. Clinical and pathological features of Crimean-Congo haemorrhagic fever. Crimean Congo hemorrhagic fever. A global perspective 2007, 207-220. Springer, Dordrecht, The Netherlands. O. Ergonul, C.A. Whitehouse (Eds.).
6. Anagnostou V., Papa A. Evolution of Crimean-Congo hemorrhagic fever virus. Infect Genet Evol 2009, 9:948-954.
7. Papa A., Dalla V., Papadimitriou E., Kartalis G.N., Antoniadis A. Emergence of Crimean-Congo haemorrhagic fever in Greece. Clin Microbiol Infect 2010, 16:843-847.
8. ProMED-mail post. Crimean-Congo hem. fever - Uganda (03): (KM, AG) fatal; 2013.
9. Karti S.S., Odabasi Z., Korten V., Yilmaz M., Sonmez M., Caylan R., et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis 2004, 10:1379-1384.
10. Mishra A.C., Mehta M., Mourya D.T., Gandhi S. Crimean-Congo haemorrhagic fever in India. Lancet 2011, 378:372.
11. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol 1979, 15:307-417.
12. Estrada-Pena A., Jameson L., Medlock J., Vatansever Z., Tishkova F. Unraveling the ecological complexities of tick-associated Crimean-Congo hemorrhagic Fever virus transmission: a gap analysis for the Western palearctic. Vector Borne Zoonotic Dis 2012, 12:743-752.
13. Watts D.M., Ksiazek T.G., Linthicum K.J. Crimean-Congo hemorrhagic fever. The arboviruses: epidemiology and ecology 1988, CRS Press, Boca Raton, FL. T.P. Monath (Ed.).
14. Shepherd A.J., Swanepoel R., Cornel A.J., Mathee O. Experimental studies on the replication and transmission of Crimean-Congo hemorrhagic fever virus in some African tick species. Am J Trop Med Hyg 1989, 40:326-331.
15. Albayrak H., Ozan E., Kurt M. Molecular detection of Crimean-Congo Haemorrhagic Fever Virus (CCHFV) but not West Nile Virus (WNV) in hard ticks from provinces in Northern Turkey. Zoonoses Public Health 2010, 57:e156-e160.
16. Tekin S., Bursali A., Mutluay N., Keskin A., Dundar E. Crimean-Congo hemorrhagic fever virus in various ixodid tick species from a highly endemic area. Vet Parasitol 2011, 186:546-552.
17. Telmadarraiy Z., Ghiasi S.M., Moradi M., Vatandoost H., Eshraghian M.R., Faghihi F., et al. A survey of Crimean-Congo haemorrhagic fever in livestock and ticks in Ardabil Province, Iran during 2004-2005. Scand J Infect Dis 2010, 42:137-141.
18. Hartemink N.A., Randolph S.E., Davis S.A., Heesterbeek J.A. The basic reproduction number for complex disease systems: defining R(0) for tick-borne infections. Am Nat 2008, 171:743-754.
19. Randolph S.E. The shifting landscape of tick-borne zoonoses: tick-borne encephalitis and Lyme borreliosis in Europe. Philos Trans R Soc Lond B Biol Sci 2001, 356:1045-1056.
20. Sumilo D., Asokliene L., Bormane A., Vasilenko V., Golovljova I., Randolph S.E. Climate change cannot explain the upsurge of tick-borne encephalitis in the Baltics. PLoS ONE 2007, 2:e500.
21. Sumilo D., Bormane A., Vasilenko V., Golovljova I., Asokliene L., Zygutiene M., et al. Upsurge of tick-borne encephalitis in the Baltic States at the time of political transition, independent of changes in public health practices. Clin Microbiol Infect 2009, 15:75-80.
22. Jaenson T., Lindgren E. The range of Ixodes ricinus and the risk of contracting Lyme borreliosis will increase northwards when the vegetation period becomes longer. Ticks Tick Borne Dis 2011, 2:44-49.
23. Estrada-Pena A., Martinez M., Munoz M.J. A population model to describe the distribution and seasonal dynamics of the tick Hyalomma marginatum in the Mediterranean Basin. Transbound Emerg Dis 2011, 58:213-223.
24. Estrada-Pena A.N.S., Estrada-Sánchez A. An assessment of the distribution and spread of the tick Hyalomma marginatum in the western Palearctic under different climate scenarios. Vector Borne Zoonotic Dis 2012, 12:758-768.
25. Estrada-Pena A., Ruiz-Fons F., Acevedo P., Gortazar C., de la Fuente J. Factors driving the circulation and possible expansion of Crimean-Congo hemorrhagic fever virus in the western Palearctic. J Appl Microbiol 2013, 114(1):278-286.
26. Gale P., Estrada-Pena A., Martinez M., Ulrich R.G., Wilson A., Capelli G., et al. The feasibility of developing a risk assessment for the impact of climate change on the emergence of Crimean-Congo haemorrhagic fever in livestock in Europe: a review. J Appl Microbiol 2010, 108:1859-1870.
27. Estrada-Pena A., Vatansever Z., Gargili A., Ergonul O. The trend towards habitat fragmentation is the key factor driving the spread of Crimean-Congo haemorrhagic fever. Epidemiol Infect 2010, 138:1194-1203.
28. Ergonul O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006, 6:203-214.
29. Bray M., Geisbert T.W. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005, 37:1560-1566.
30. Bray M., Pilch R. Filoviruses: recent advances and future challenges. Expert Rev Anti Infect Ther 2006, 4:917-921.
31. Chen S.T., Lin Y.L., Huang M.T., Wu M.F., Cheng S.C., Lei H.Y., et al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature 2008, 453:672-676.
32. Chen H.C., Hofman F.M., Kung J.T., Lin Y.D., Wu-Hsieh B.A. Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol 2007, 81:5518-5526.
33. Lei H.Y., Yeh T.M., Liu H.S., Lin Y.S., Chen S.H., Liu C.C. Immunopathogenesis of dengue virus infection. J Biomed Sci 2001, 8:377-388.
34. Connolly-Andersen A.M., Douagi I., Kraus A.A., Mirazimi A. Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology 2009, 390:157-162.
35. Peyrefitte C.N., Perret M., Garcia S., Rodrigues R., Bagnaud A., Lacote S., et al. Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells. J Gen Virol 2010, 91:189-198.
36. Papa A., Bino S., Velo E., Harxhi A., Kota M., Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol 2006, 36:272-276.
37. Ergonul O., Tuncbilek S., Baykam N., Celikbas A., Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006, 193:941-944.
38. Ozturk B., Kuscu F., Tutuncu E., Sencan I., Gurbuz Y., Tuzun H. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. J Clin Virol 2010, 47:115-119.
39. Connolly-Andersen A.M., Moll G., Andersson C., Akerstrom S., Karlberg H., Douagi I., et al. Crimean-Congo hemorrhagic fever virus activates endothelial cells. J Virol 2011, 85:7766-7774.
40. Karlberg H., Tan Y.J., Mirazimi A. Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection. J Biol Chem 2011, 286:3227-3234.
41. Rodrigues R., Paranhos-Baccala G., Vernet G., Peyrefitte C.N. Crimean-Congo hemorrhagic fever virus-infected hepatocytes induce ER-stress and apoptosis crosstalk. PLoS ONE 2012, 7:e29712.
42. Hertzog P.J., O'Neill L.A., Hamilton J.A. The interferon in TLR signaling: more than just antiviral. Trends Immunol 2003, 24:534-539.
43. Le Bon A., Tough D.F. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 2002, 14:432-436.
44. Andersson I., Lundkvist A., Haller O., Mirazimi A. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J Med Virol 2006, 78:216-222.
45. Andersson I., Karlberg H., Mousavi-Jazi M., Martinez-Sobrido L., Weber F., Mirazimi A. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J Med Virol 2008, 80:1397-1404.
46. Habjan M., Andersson I., Klingstrom J., Schumann M., Martin A., Zimmermann P., et al. Processing of genome 5' termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS ONE 2008, 3:e2032.
47. Frias-Staheli N., Giannakopoulos N.V., Kikkert M., Taylor S.L., Bridgen A., Paragas J., et al. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2007, 2:404-416.
48. Bereczky S., Lindegren G., Karlberg H., Akerstrom S., Klingstrom J., Mirazimi A. Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice. J Gen Virol 2010, 91:1473-1477.
49. Bente D.A., Alimonti J.B., Shieh W.J., Camus G., Stroher U., Zaki S., et al. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol 2010, 84:11089-11100.
50. Zivcec M., Safronetz D., Scott D., Robertson S., Ebihara H., Feldmann H. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon alpha/beta receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. J Infect Dis 2013, 207:1909-1921.
51. Yapar M., Aydogan H., Pahsa A., Besirbellioglu B.A., Bodur H., Basustaoglu A.C., et al. Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse transcriptase-PCR. Jpn J Infect Dis 2005, 58:358-362.
52. Papa A., Drosten C., Bino S., Blow J., O'Guinn M.L., Schmaljohn C., et al. Viral load and Crimean-Congo hemorrhagic fever. Emerg Infect Dis 2007, 13:805-806.
53. Ibrahim S.M., Aitichou M., Hardick J., Blow J., O'Guinn M.L., Schmaljohn C. Detection of Crimean-Congo hemorrhagic fever, Hanta, and sandfly fever viruses by real-time RT-PCR. Methods Mol Biol 2011, 665:357-368.
54. Garrison A.R., Alakbarova S., Kulesh D.A., Shezmukhamedova D., Khodjaev S., Endy T.P., et al. Development of a TaqMan minor groove binding protein assay for the detection and quantification of Crimean-Congo hemorrhagic fever virus. Am J Trop Med Hyg 2007, 77:514-520.
55. Duh D., Saksida A., Petrovec M., Ahmeti S., Dedushaj I., Panning M., et al. Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg Infect Dis 2007, 13:1769-1772.
56. Wolfel R., Paweska J.T., Petersen N., Grobbelaar A.A., Leman P.A., Hewson R., et al. Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis 2007, 13:1097-1100.
57. Kondiah K., Swanepoel R., Paweska J.T., Burt F.J. A simple-probe real-time PCR assay for genotyping reassorted and non-reassorted isolates of Crimean-Congo hemorrhagic fever virus in southern Africa. J Virol Methods 2010, 169:34-38.
58. Atkinson B., Latham J., Chamberlain J., Logue C., O'Donoghue L., Osborne J., et al. Sequencing and phylogenetic characterisation of a fatal Crimean-Congo haemorrhagic fever case imported into the United Kingdom, October 2012. Euro Surveill 2012, 17.
59. Wolfel R., Paweska J.T., Petersen N., Grobbelaar A.A., Leman P.A., Hewson R., et al. Low-density macroarray for rapid detection and identification of Crimean-Congo hemorrhagic fever virus. J Clin Microbiol 2009, 47:1025-1030.
60. Filippone C., Marianneau P., Murri S., Mollard N., Avsic-Zupanc T., Chinikar S., et al. Molecular diagnostic and genetic characterization of highly pathogenic viruses: application during Crimean-Congo haemorrhagic fever virus outbreaks in Eastern Europe and the Middle East. Clin Microbiol Infect 2013, 19:E118-E128.
61. Ke R., Zorzet A., Göransson J., Lindegren G., Sharifi-Mood B., Chinikar S., et al. Colorimetric nucleic acid testing assay for RNA virus detection based on circle-to-circle amplification of padlock probes. J Clin Microbiol 2011, 49:4279-4285.
62. Osman H.A., Eltom K.H., Musa N.O., Bilal N.M., Elbashir M.I., Aradaib I.E. Development and evaluation of loop-mediated isothermal amplification assay for detection of Crimean Congo hemorrhagic fever virus in Sudan. J Virol Methods 2013, 190:4-10.
63. Andersson C., Henriksson S., Magnusson K.E., Nilsson M., Mirazimi A. In situ rolling circle amplification detection of Crimean Congo hemorrhagic fever virus (CCHFV) complementary and viral RNA. Virology 2012, 426:87-92.
64. Emmerich P., Avsic-Zupanc T., Chinikar S., Saksida A., Thome-Bolduan C., Parczany-Hartmann A., et al. Early serodiagnosis of acute human Crimean-Congo hemorrhagic fever virus infections by novel capture assays. J Clin Virol 2010, 48:294-295.
65. Dowall S.D., Richards K.S., Graham V.A., Chamberlain J., Hewson R. Development of an indirect ELISA method for the parallel measurement of IgG and IgM antibodies against Crimean-Congo haemorrhagic fever (CCHF) virus using recombinant nucleoprotein as antigen. J Virol Methods 2012, 179:335-341.
66. Vanhomwegen J., Alves M.J., Zupanc T.A., Bino S., Chinikar S., Karlberg H., et al. Diagnostic assays for Crimean-Congo hemorrhagic fever. Emerg Infect Dis 2012, 18:1958-1965.
67. Escadafal C., Olschlager S., Avsic-Zupanc T., Papa A., Vanhomwegen J., Wolfel R., et al. First international external quality assessment of molecular detection of Crimean-Congo hemorrhagic fever virus. PLoS Negl Trop Dis 2012, 6:e1706.
68. Canakoglu N., Berber E., Ertek M., Yoruk M.D., Tonbak S., Bolat Y., et al. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus. Virol J 2013, 10:6.
69. Keshtkar-Jahromi M., Kuhn J.H., Christova I., Bradfute S.B., Jahrling P.B., Bavari S. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antiviral Res 2011, 90:85-92.
70. Ergonul O. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res 2008, 78:125-131.
71. Koksal I., Yilmaz G., Aksoy F., Aydin H., Yavuz I., Iskender S., et al. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol: Off Publ Pan Am Soc Clin Virol 2010, 47:65-68.
72. Leblebicioglu H., Bodur H., Dokuzoguz B., Elaldi N., Guner R., Koksal I., et al. Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis 2012, 12:805-811.
73. Dilber E., Cakir M., Erduran E., Koksal I., Bahat E., Mutlu M., et al. High-dose methylprednisolone in children with Crimean-Congo haemorrhagic fever. Trop Doct 2010, 40:27-30.
74. Tignor G.H., Hanham C.A. Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res 1993, 22:309-325.
75. Tasdelen Fisgin N., Ergonul O., Doganci L., Tulek N. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur J Clin Microbiol Infect Dis 2009, 28:929-933.
76. Yilmaz G.R., Buzgan T., Irmak H., Safran A., Uzun R., Cevik M.A., et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis 2009, 13:380-386.
77. Koksal I., Yilmaz G., Aksoy F., Aydin H., Yavuz I., Iskender S., et al. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J Clin Virol 2010, 47:65-68.
78. Ascioglu S., Leblebicioglu H., Vahaboglu H., Chan K.A. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J Antimicrob Chemother 2011, 66:1215-1222.
79. Soares-Weiser K., Thomas S., Thomson G., Garner P. Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis. BMC Infect Dis 2010, 10:207.
80. Jabbari A., Besharat S., Abbasi A., Moradi A., Kalavi K. Crimean-Congo hemorrhagic fever: case series from a medical center in Golestan province, Northeast of Iran (2004). Indian J Med Sci 2006, 60:327-329.
81. Flusin O., Vigne S., Peyrefitte C.N., Bouloy M., Crance J.M., Iseni F. Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin. Virol J 2011, 8:249.
82. Maltezou H.C., Papa A. Crimean-Congo hemorrhagic fever: epidemiological trends and controversies in treatment. BMC Med 2011, 9:131.
83. Christova I., Di Caro A., Papa A., Castilletti C., Andonova L., Kalvatchev N., et al. Crimean-Congo hemorrhagic fever, southwestern Bulgaria. Emerg Infect Dis 2009, 15:983-985.
84. Kubar A., Haciomeroglu M., Ozkul A., Bagriacik U., Akinci E., Sener K., et al. Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR. Jpn J Infect Dis 2011, 64:439-443.
85. Christova I., Kovacheva T., Georgieva D., Ivanova S., Argirov D. Vaccine against Congo-Crimean haemorrhagic fever virus - Bulgarian input in fighting the disease. Probl Inf Parasit Dis 2010, 37:7-8.
86. Tarantola A., Ergonul O., Tattevin P. Estimates and prevention of Crimean-Congo hemorrhagic fever risks for health-care workers. Crimean Congo hemorrhagic fever. A global perspective 2007, 281-294. Springer, Dortrecht. O. Ergonul, C.A. Whitehouse (Eds.).
87. Ergonul O. Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol 2012, 2:215-220.
88. Tütüncü E.E.G.Y., Ozturk B., Kuscu F., Sencan I. Crimean Congo haemorrhagic fever, precautions and ribavirin prophylaxis: a case report. Scand J Infect Dis 2009, 41:378-380.
89. Tarantola A., Ergonul O.P.T. Estimates and prevention of Crimean Congo hemorrhagic fever risks for health careworkers. Crimean-Congo hemorrhagic fever: a global perspective 2007, 281-294. Springer, Dordrecht, NL. O. Ergonul, C.A. Whitehouse (Eds.).
90. Tutuncu E.E., Gurbuz Y., Ozturk B., Kuscu F., Sencan I. Crimean Congo haemorrhagic fever, precautions and ribavirin prophylaxis: a case report. Scand J Infect Dis 2009, 41:378-380.
91. Mertens M., Schmidt K., Ozkul A., Groschup M.H. The impact of Crimean-Congo hemorrhagic fever virus on public health. Antiviral Res 2013, 98:248-260.